Flemming Andersen
Overview
Explore the profile of Flemming Andersen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
229
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wiegell S, Fredman G, Andersen F, Bjerring P, Paasch U, Haedersdal M
Photodiagnosis Photodyn Ther
. 2024 Dec;
51:104445.
PMID: 39674293
Background: Since recurrences and new AKs commonly are observed after treatment long-term effects of field-directed therapies for AKs are crucial. Thus, we evaluated the 6- and 12-month efficacy and satisfaction...
2.
Fredman G, Haedersdal M, Philipsen P, Andersen F, Bjerring P, Wiegell S, et al.
Acta Derm Venereol
. 2024 Nov;
104:adv42190.
PMID: 39585185
Treatment-resistant actinic keratosis (AK) is of concern in clinical practice, often requiring retreatment. Microvascular assessments might help differentiate treatment-resistant from treatment-responsive AKs, enabling targeted treatment. Using dynamic optical coherence tomography,...
3.
Grove G, Reedtz G, Vangsgaard B, Eskandarani H, Haedersdal M, Andersen F, et al.
Skin Res Technol
. 2024 Oct;
30(10):e70056.
PMID: 39366915
Background: The development of artificial intelligence (AI) is rapidly expanding, showing promise in the dermatological field. Skin checks are a resource-heavy challenge that could potentially benefit from AI-tool assistance, particularly...
4.
Fredman G, Fuchs C, Wenande E, Philipsen P, Untracht G, Andersen F, et al.
Exp Dermatol
. 2024 Aug;
33(8):e15153.
PMID: 39138644
Actinic keratosis (AK) classification relies on clinical characteristics limited to the skin's surface. Incorporating sub-surface evaluation may improve the link between clinical classification and the underlying pathology. We aimed to...
5.
Borgwardt L, Brok J, Andersen K, Madsen J, Gillings N, Fosbol M, et al.
J Nucl Med
. 2024 Jul;
65(8):1286-1292.
PMID: 38960713
Meta-[I]iodobenzylguanidine ([I]MIBG) scintigraphy with SPECT/CT is the standard of care for diagnosing and monitoring neuroblastoma. Replacing [I]MIBG with the new PET tracer meta-[F]fluorobenzylguanidine ([F]MFBG) and further improving sensitivity and reducing...
6.
Pihl C, Andersen F, Bjerring P, Haedersdal M, Lerche C
Dermatology
. 2024 Apr;
240(3):453-461.
PMID: 38599196
Introduction: Ultraviolet radiation (UVR) is the primary risk factor for keratinocyte carcinomas. Oral supplementation with nicotinamide (NAM) is reported to reduce the formation of new keratinocyte carcinomas. NAM's photoprotection is...
7.
Wiegell S, Fredman G, Andersen F, Bjerring P, Paasch U, Haedersdal M
Photodiagnosis Photodyn Ther
. 2024 Mar;
46:104069.
PMID: 38555038
Background: Daylight photodynamic therapy (dPDT) and topical 5-fluorouracil (5-FU) are each effective treatments for thin grade I actinic keratosis (AKs), but less so for thicker grade II-III AKs. Prolonged topical...
8.
Pihl C, Bjerring P, Andersen F, Haedersdal M, Lerche C
Photochem Photobiol Sci
. 2024 Feb;
23(3):517-526.
PMID: 38337129
Squamous cell carcinoma represents the second most common type of keratinocyte carcinoma with ultraviolet radiation (UVR) making up the primary risk factor. Oral photoprotection aims to reduce incidence rates through...
9.
Trettin B, Boe Danbjorg D, Andersen F, Feldman S, Agerskov H
JMIR Dermatol
. 2023 Aug;
4(1):e26673.
PMID: 37632817
Background: In Denmark, patients with psoriasis undergoing biological treatment have regular follow-ups, typically every 3 months. This may pose a challenge for patients who live far away from the hospital....
10.
Trettin B, Boe Danbjorg D, Andersen F, Feldman S, Agerskov H
JMIR Dermatol
. 2023 Aug;
4(1):e28882.
PMID: 37632803
Background: Teledermatology has the potential to help deliver health care by transforming the relationship between patients and health care professionals (HCPs), shifting the power of consultation so that patients can...